Rankings
▼
Calendar
PHAT FY 2023 Earnings — Phathom Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
PHAT
Phathom Pharmaceuticals, Inc.
$891M
FY 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$682,000
Gross Profit
$515,000
75.5% margin
Operating Income
-$167M
-24532.6% margin
Net Income
-$202M
-29558.9% margin
EPS (Diluted)
$-3.93
Cash Flow
Operating Cash Flow
-$138M
Free Cash Flow
-$139M
Stock-Based Comp.
$45M
Balance Sheet
Total Assets
$414M
Total Liabilities
$487M
Stockholders' Equity
-$73M
Cash & Equivalents
$381M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$682,000
$0
—
Gross Profit
$515,000
-$620,000
+183.1%
Operating Income
-$167M
-$172M
+3.0%
Net Income
-$202M
-$198M
-2.0%
← Q4 2022
All Quarters
Q1 2023 →